Aim: To investigate the expression of LAIR-1 in patients with tumors and the function of LAIR-1 in anticancer immunity.
Methods: A sandwich ELISA was employed to detect the serum sLAIR-1 from tumor patients and healthy individuals. The expression of LAIR-1 in CD4+ T cells, CD8+ T cells, NK cells and B cells isolated from the peripheral blood of cancer patients was examined by fluorescence staining and flow cytometry.
Results: The level of serum sLAIR-1 in tumor patients was higher than that in healthy individuals [4.6+/-3.2 microg/L vs 3.9+/-3.0 microg/L, P<0.05]. NK cells, CD4+ T cells and CD8+ T cells expressed the up-regulated LAIR-1. The ratio of CD4/CD8 in lung cancer patients decreased significantly while the percentage of B cells in cancer patients increased greatly compared with healthy individuals.
Conclusion: The expression of LAIR-1 is up-regulated in tumor patients, which may contribute to cancer immune escape.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironment.
J Ovarian Res
December 2024
Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, 720 Westview Dr SW, HG 341B, Atlanta, GA, 30310, USA.
Article Synopsis
- High-grade serous ovarian cancer (HGSOC) is a complex and aggressive cancer type marked by significant molecular diversity, challenging current treatment efforts.
- This study analyzed four mRNA subtypes—immunoreactive, differentiated, proliferative, and mesenchymal—focusing on their gene expression profiles, immune microenvironment, and connections to clinical traits like survival and age.
- Key findings showed that the immunoreactive subtype had high immune cell infiltration linked to better immune responses, while the proliferative subtype was associated with growth and cancer progression, highlighting the need for subtype-specific treatment strategies.
Leukemic B cells expression of CD200 and Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1, CD305) in Chronic Lymphocytic Leukemia patients in relation to Treg frequency.
Pathol Res Pract
November 2024
Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abbasia, Cairo 11566, Egypt. Electronic address:
Background: Chronic lymphocytic leukemia (CLL) is characterized by a wide range of tumor-induced immune alterations. Regulatory T cells (Treg) play a central role in these immune responses. CD200 and Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1, CD305) are inhibitory markers said to be involved in Treg immune response.
View Article and Find Full Text PDFLAIR-1 and PECAM-1 function via the same signaling pathway to inhibit GPVI-mediated platelet activation.
Res Pract Thromb Haemost
August 2024
Institut National de la Santé et de la Recherche Médicale (INSERM), Etablissement Français du Sang (EFS) Grand-Est, Unité Mixte de Recherche (UMR)-S 1255, Université de Strasbourg, Strasbourg, France.
Background: Inhibition of platelet responsiveness is important for controlling thrombosis. It is well established that platelet endothelial cell adhesion molecule-1 (PECAM-1) serves as a physiological negative regulator of platelet-collagen interactions. We recently demonstrated that leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is a negative regulator of platelet production and reactivity.
View Article and Find Full Text PDFImpaired LAIR-1-mediated immune control due to collagen degradation in fibrosis.
J Autoimmun
June 2024
Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands. Electronic address:
Tissue repair is disturbed in fibrotic diseases like systemic sclerosis (SSc), where the deposition of large amounts of extracellular matrix components such as collagen interferes with organ function. LAIR-1 is an inhibitory collagen receptor highly expressed on tissue immune cells. We questioned whether in SSc, impaired LAIR-1-collagen interaction is contributing to the ongoing inflammation and fibrosis.
View Article and Find Full Text PDF[leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) inhibits proliferation and promotes apoptosis of human HEL cells with JAK2 V617F mutation by blocking the JAK/STAT and PI3K/AKT signaling pathways].
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
March 2024
Department of Immunology of Basic Medical College, Binzhou Medical University, Yantai 264000, China. *Corresponding author, E-mail:
Objective To investigate the role of human leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) in the regulation of Janus kinase/signal transducers and activators of transcription (JAK/STAT) and phosphatidylinositol 3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT /mTOR) signaling pathways in human acute myeloid leukemia HEL cells carrying the JAK2 V617F mutation, along with its effects on cell proliferation and apoptosis. MethodsThe JAK2 V617F mutation was identified using reverse transcription PCR and gene sequencing. The protein phosphatase (PTP) recruited by LAIR-1 was determined through co-immunoprecipitation and Western blot analysis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!